A comparison of two workflows for regulome and transcriptome‐based prioritization of genetic variants associated with myocardial mass. Issue 6 (30th May 2019)

• Record Type: Journal Article
• Authors: Manduchi, Elisabetta; Hemerich, Daiane; van Setten, Jessica; Tragante, Vinicius; Harakalova, Magdalena; Pei, Jiayi; Williams, Scott M.; van der Harst, Pim; Asselbergs, Folkert W.; Moore, Jason H.
• Is Part Of: Genetic epidemiology. Volume 43:Issue 6(2019)
• Page Start: 717
• Page End: 726
• Publication Date: 2019-05-30
• Subjects: functional genomics -- GWAS -- left ventricular mass -- SNP preselection; Genetic epidemiology -- Periodicals; Heredity -- Periodicals; Medical geography -- Periodicals; 614
• DOI: 10.1002/gepi.22215
• Languages: English
• ISSNs: 0741-0395

Abstract

Abstract: A typical task arising from main effect analyses in a Genome Wide Association Study (GWAS) is to identify single nucleotide polymorphisms (SNPs), in linkage disequilibrium with the observed signals, that are likely causal variants and the affected genes. The affected genes may not be those closest to associating SNPs. Functional genomics data from relevant tissues are believed to be helpful in selecting likely causal SNPs and interpreting implicated biological mechanisms, ultimately facilitating prevention and treatment in the case of a disease trait. These data are typically used post GWAS analyses to fine‐map the statistically significant signals identified agnostically by testing all SNPs and applying a multiple testing correction. The number of tested SNPs is typically in the millions, so the multiple testing burden is high. Motivated by this, in this study we investigated an alternative workflow, which consists in utilizing the available functional genomics data as a first step to reduce the number of SNPs tested for association. We analyzed GWAS on electrocardiographic QRS duration using these two workflows. The alternative workflow identified more SNPs, including some residing in loci not discovered with the typical workflow. Moreover, the latter are corroborated by other reports on QRS duration. This indicates the potential value of incorporating functional genomics information at the onset in GWAS analyses.